Retina Implant AG Researcher and Trial Patient to Present at International Retina Congress

Retina Implant AG Researcher and Trial Patient to Present at International Retina Congress PR Newswire HAMBURG, Germany, July 10, 2012 - Global Momentum Continues for Retina Implant AG's Second Human Clinical Trial HAMBURG, Germany, July 10, 2012 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that results from the Company's second human clinical trial will be presented at the Retina International World Congress. The biennial Congress taking place in Hamburg, Germany from July 13-15 expects 500 attendees comprised of patients, caregivers and industry luminaries, making it the world's largest retinal-focused conference. Professor Eberhart Zrenner, lead clinical trial investigator for Retina Implant AG and Miikka Terho, a patient from the Company's first human clinical trial, will both present at the meeting. On Saturday, July 14 from 1:30-2:00 p.m. CEST, Professor Zrenner and Terho will co-present a session designed for patients and caregivers titled, "Vision in daily life with the subretinal implant." The session will discuss the visual results Terho experienced when he participated in Retina Implant's first human clinical trial. In addition, Professor Zrenner will provide a Key note speech during the event and will also present the scientific session, "Artificial vision-an overview," at 9:50-10:15 a.m. CEST on Sunday, July 15.